FDA 510(k)
The latest platform provides developers and providers direct control over streaming health data.
A newly published notice from the FDA suggests a new capability for the Alphabet subsidiary's clinical research wearable.
The Air Next is designed for patients with respiratory conditions such as asthma, COPD and cystic fibrosis.
The company has struck deals with VivaLNK and MIR, and is eying "more than 50 integrations by the end of next year."
The new tool is a clinical-grade ACR test used to identify chronic kidney disease.
Biobeat's connected remote monitoring device is currently available as either a wristwatch or an adhesive patch.
The company's latest algorithm extracts raw data from a variety of sensors and unifies them into a uniform vital signs reading, MobiHealthNews exclusively learned.
The technology has a built-in sensor that can send usage data to a corresponding smartphone app.
Both companies are ramping up the pace of their FDA clearances.
Recently deployed in US and UK hospitals, the company's upper-arm wearable and accompanying platform may now go home with the patient.